QIAGEN N.V. QGEN recently launched Ingenuity Pathway Analysis (“IPA”) Interpret, a new feature designed to simplify and accelerate the interpretation of complex biological data. Leveraging AI ...
Qiagen (QGEN) announced the launch of Ingenuity Pathway Analysis Interpret, a new feature designed to simplify and accelerate the interpretation of complex biological data. Leveraging AI technology, ...
REDWOOD CITY, Calif. & VENLO, the Netherlands--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN, Frankfurt Prime Standard: QIA) today announced the launch of Ingenuity Pathway Analysis (IPA) Interpret, a new ...
Single-cell RNA sequencing has emerged as an important technology that can reveal gene expression differences between different cell types. This webinar will demonstrate how bioinformatics solutions ...
QIAGEN Significantly Expands its Offering of Assay Panels for Next-generation Sequencing (NGS) Complemented by Ingenuity Analysis and Interpretation Capabilities Expansion to about 20 validated gene ...
“Adoption of QIAGEN's universal bioinformatics solutions is growing rapidly as we continue to integrate and expand the capabilities of our applications and knowledge bases from CLC bio, Ingenuity and ...
Ingenuity Systems is the global market leader in applications to quickly analyze and accurately interpret rapidly growing volumes of genomic data Suite of web-based applications powered by a unique ...
Single-cell RNA sequencing (scRNA-seq) is an important technology that reveals gene expression differences between different cell types. Yet scRNA-seq data can be challenging to analyze and interpret.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results